HeartBeam, Inc. (BEATW)
USD 0.51
(0.0%)
USD 0.51
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 15.31 Million USD | 17.52% |
| 2022 | 13.03 Million USD | 470.28% |
| 2021 | 2.28 Million USD | 189.97% |
| 2020 | 788 Thousand USD | 168.03% |
| 2019 | 294 Thousand USD | -99.82% |
| 2018 | 166.48 Million USD | 23.3% |
| 2017 | 135.02 Million USD | 44.27% |
| 2016 | 93.58 Million USD | 12.78% |
| 2015 | 82.97 Million USD | 1.19% |
| 2014 | 82 Million USD | 16.03% |
| 2013 | 70.67 Million USD | 10.97% |
| 2012 | 63.69 Million USD | -20.99% |
| 2011 | 80.61 Million USD | -7.84% |
| 2010 | 87.47 Million USD | -12.18% |
| 2009 | 99.6 Million USD | 50.98% |
| 2008 | 65.97 Million USD | 39.7% |
| 2007 | 47.22 Million USD | 83.68% |
| 2006 | 25.7 Million USD | 0.0% |
| 2005 | - USD | -100.0% |
| 2004 | 25.35 Million USD | 69.23% |
| 2003 | 14.98 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 4.78 Million USD | 16.43% |
| 2024 Q2 | 5.09 Million USD | 6.4% |
| 2023 Q3 | 3.73 Million USD | 12.83% |
| 2023 Q2 | 3.31 Million USD | -20.31% |
| 2023 Q4 | 4.1 Million USD | 9.95% |
| 2023 FY | 15.31 Million USD | 17.52% |
| 2023 Q1 | 4.15 Million USD | 11.15% |
| 2022 Q3 | 3.61 Million USD | 2.12% |
| 2022 Q2 | 3.53 Million USD | 64.57% |
| 2022 Q1 | 2.14 Million USD | 60.18% |
| 2022 FY | 13.03 Million USD | 470.28% |
| 2022 Q4 | 3.73 Million USD | 3.57% |
| 2021 Q2 | 337 Thousand USD | 106.75% |
| 2021 Q4 | 1.34 Million USD | 200.67% |
| 2021 Q1 | 163 Thousand USD | -37.55% |
| 2021 Q3 | 446 Thousand USD | 32.34% |
| 2021 FY | 2.28 Million USD | 189.97% |
| 2020 Q1 | 100 Thousand USD | -99.79% |
| 2020 Q2 | 154 Thousand USD | 54.0% |
| 2020 Q3 | 272 Thousand USD | 76.62% |
| 2020 Q4 | 261 Thousand USD | -4.04% |
| 2020 FY | 788 Thousand USD | 168.03% |
| 2019 Q4 | 48.57 Million USD | 5.86% |
| 2019 FY | 294 Thousand USD | -99.82% |
| 2019 Q2 | 46.91 Million USD | 5.78% |
| 2019 Q1 | 44.35 Million USD | 11.57% |
| 2019 Q3 | 45.88 Million USD | -2.2% |
| 2018 Q1 | 42.57 Million USD | 11.03% |
| 2018 FY | 166.48 Million USD | 23.3% |
| 2018 Q2 | 44.86 Million USD | 5.38% |
| 2018 Q3 | 39.28 Million USD | -12.43% |
| 2018 Q4 | 39.75 Million USD | 1.18% |
| 2017 Q4 | 38.34 Million USD | -10.36% |
| 2017 Q1 | 27.21 Million USD | 9.52% |
| 2017 FY | 135.02 Million USD | 44.27% |
| 2017 Q2 | 26.68 Million USD | -1.94% |
| 2017 Q3 | 42.77 Million USD | 60.31% |
| 2016 Q4 | 24.84 Million USD | 7.31% |
| 2016 Q2 | 23.75 Million USD | 8.79% |
| 2016 Q1 | 21.83 Million USD | -0.48% |
| 2016 FY | 93.58 Million USD | 12.78% |
| 2016 Q3 | 23.15 Million USD | -2.54% |
| 2015 Q1 | 20.55 Million USD | -1.71% |
| 2015 FY | 82.97 Million USD | 1.19% |
| 2015 Q4 | 21.94 Million USD | 11.33% |
| 2015 Q3 | 19.7 Million USD | -5.14% |
| 2015 Q2 | 20.77 Million USD | 1.06% |
| 2014 Q2 | 20.39 Million USD | 1.13% |
| 2014 Q3 | 20.32 Million USD | -0.32% |
| 2014 Q4 | 20.91 Million USD | 2.89% |
| 2014 FY | 82 Million USD | 16.03% |
| 2014 Q1 | 20.16 Million USD | 12.18% |
| 2013 FY | 70.67 Million USD | 10.97% |
| 2013 Q3 | 17.56 Million USD | 1.97% |
| 2013 Q1 | 17.91 Million USD | 115.14% |
| 2013 Q4 | 17.97 Million USD | 2.32% |
| 2013 Q2 | 17.22 Million USD | -3.82% |
| 2012 Q2 | 17.66 Million USD | -6.66% |
| 2012 Q4 | 8.32 Million USD | -55.68% |
| 2012 FY | 63.69 Million USD | -20.99% |
| 2012 Q1 | 18.92 Million USD | 3.47% |
| 2012 Q3 | 18.78 Million USD | 6.35% |
| 2011 FY | 80.61 Million USD | -7.84% |
| 2011 Q1 | 21.81 Million USD | 5.98% |
| 2011 Q2 | 20.64 Million USD | -5.36% |
| 2011 Q3 | 19.86 Million USD | -3.75% |
| 2011 Q4 | 18.28 Million USD | -7.96% |
| 2010 FY | 87.47 Million USD | -12.18% |
| 2010 Q4 | 20.58 Million USD | -7.26% |
| 2010 Q3 | 22.19 Million USD | 4.99% |
| 2010 Q1 | 18.91 Million USD | -26.97% |
| 2010 Q2 | 21.13 Million USD | 11.74% |
| 2009 FY | 99.6 Million USD | 50.98% |
| 2009 Q4 | 25.9 Million USD | -1.39% |
| 2009 Q1 | 23.08 Million USD | 32.9% |
| 2009 Q2 | 24.34 Million USD | 5.43% |
| 2009 Q3 | 26.26 Million USD | 7.91% |
| 2008 Q2 | 16.35 Million USD | 6.76% |
| 2008 Q4 | 17.37 Million USD | 2.7% |
| 2008 FY | 65.97 Million USD | 39.7% |
| 2008 Q1 | 15.32 Million USD | 121.06% |
| 2008 Q3 | 16.91 Million USD | 3.4% |
| 2007 Q1 | - USD | 100.0% |
| 2007 Q3 | - USD | -100.0% |
| 2007 Q4 | -72.75 Million USD | 0.0% |
| 2007 Q2 | 10.99 Million USD | 0.0% |
| 2007 FY | 47.22 Million USD | 83.68% |
| 2006 Q3 | - USD | 0.0% |
| 2006 FY | 25.7 Million USD | 0.0% |
| 2006 Q4 | -38.41 Million USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2005 FY | - USD | -100.0% |
| 2004 FY | 25.35 Million USD | 69.23% |
| 2003 FY | 14.98 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| CareCloud, Inc. | 93.35 Million USD | 83.596% |
| Augmedix, Inc. | 40.3 Million USD | 62.005% |
| BrightSpring Health Services, Inc. Common Stock | 1.28 Billion USD | 98.81% |
| CareCloud, Inc. | 93.35 Million USD | 83.596% |
| HealthEquity, Inc. | 401.74 Million USD | 96.188% |
| iCoreConnect Inc. | 15.12 Million USD | -1.256% |
| Inovalon Holdings, Inc. | 427.99 Million USD | 96.422% |
| Nutex Health, Inc. | 66.54 Million USD | 76.988% |
| Omnicell, Inc. | 534.79 Million USD | 97.136% |
| OneMedNet Corporation | 8.24 Million USD | -85.706% |
| Progyny, Inc. | 176.61 Million USD | 91.329% |
| Renalytix Plc | 29.04 Million USD | 47.268% |
| Schrödinger, Inc. | 318.14 Million USD | 95.186% |
| Simulations Plus, Inc. | 37.02 Million USD | 58.633% |
| SOPHiA GENETICS SA | 117.73 Million USD | 86.993% |
| Streamline Health Solutions, Inc. | 31.19 Million USD | 50.901% |
| Ontrak, Inc. | 29.47 Million USD | 48.044% |
| GE HealthCare Technologies Inc. | 5.48 Billion USD | 99.721% |
| Sharecare, Inc. | 225.97 Million USD | 93.223% |
| Aclarion, Inc. | 4.87 Million USD | -214.091% |
| CareMax, Inc. | 670.05 Million USD | 97.715% |
| Bullfrog AI Holdings, Inc. Common Stock | 5.42 Million USD | -182.165% |
| Forian Inc. | 20.59 Million USD | 25.658% |
| Bullfrog AI Holdings, Inc. Warrants | 5.42 Million USD | -182.165% |
| GeneDx Holdings Corp. | 224.28 Million USD | 93.172% |
| SCWorx Corp. | 2.71 Million USD | -463.069% |
| Minerva Surgical, Inc. | 58.14 Million USD | 73.661% |
| Definitive Healthcare Corp. | 546.47 Million USD | 97.198% |
| 10x Genomics, Inc. | 674.94 Million USD | 97.731% |
| Zhongchao Inc. | 13.92 Million USD | -9.995% |
| Accolade, Inc. | 306.51 Million USD | 95.004% |
| MSP Recovery, Inc. | 565.43 Million USD | 97.292% |
| R1 RCM Inc. | 336.6 Million USD | 95.45% |
| Spok Holdings, Inc. | 90.97 Million USD | 83.168% |
| Privia Health Group, Inc. | 134.31 Million USD | 88.599% |
| EUDA Health Holdings Limited | 4.8 Million USD | -218.834% |
| TruBridge, Inc. | 206.17 Million USD | 92.572% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 1.28 Billion USD | 98.81% |
| Sharecare, Inc. | 225.97 Million USD | 93.223% |
| Health Catalyst, Inc. | 258.73 Million USD | 94.081% |
| GoodRx Holdings, Inc. | 710.34 Million USD | 97.844% |
| Premier, Inc. | 683.65 Million USD | 97.76% |
| HealthStream, Inc. | 168.02 Million USD | 90.886% |
| Certara, Inc. | 254.08 Million USD | 93.973% |
| GeneDx Holdings Corp. | 224.28 Million USD | 93.172% |
| Ontrak, Inc. | 29.47 Million USD | 48.044% |
| SHL Telemedicine Ltd. | 34.26 Million USD | 55.31% |
| CareCloud, Inc. | 93.35 Million USD | 83.596% |
| EUDA Health Holdings Limited | 4.8 Million USD | -218.834% |
| HeartBeam, Inc. | 15.31 Million USD | 0.0% |
| Mangoceuticals, Inc. | 9.65 Million USD | -58.688% |
| CareMax, Inc. | 670.05 Million USD | 97.715% |
| Healthcare Triangle, Inc. | 18.12 Million USD | 15.509% |
| National Research Corporation | 52.52 Million USD | 70.842% |
| Aclarion, Inc. | 4.87 Million USD | -214.091% |
| OptimizeRx Corporation | 69.3 Million USD | 77.902% |